What does E A Sishkova research?

E A Sishkova studies ulcerative colitis, a chronic condition that causes inflammation in the digestive tract. Specifically, their research examines how propionyl-L-carnitine, a compound that helps cells produce energy, can enhance treatment for patients who are already receiving stable oral medications. Sishkova's work aims to provide insights into more effective therapies that can improve the quality of life for those suffering from this condition.

Key findings

  • In a clinical trial, 72% of patients taking propionyl-L-carnitine experienced a positive response to treatment, compared to just 50% in the placebo group.
  • The study indicated that propionyl-L-carnitine therapy could enhance symptom management for patients with mild-to-moderate ulcerative colitis.
  • The treatment was considered safe, with most side effects being mild and related to stomach issues.

Frequently asked questions

Does Dr. Sishkova study ulcerative colitis?
Yes, Dr. Sishkova's research specifically focuses on ulcerative colitis and potential treatments for this condition.
What treatment has Dr. Sishkova researched?
Dr. Sishkova has researched the use of propionyl-L-carnitine as a therapy for patients with ulcerative colitis.
Is Dr. Sishkova's work relevant to patients with digestive issues?
Yes, their work is highly relevant to patients suffering from ulcerative colitis and looking for new management options.

Publications in plain English

Randomised clinical trial: the efficacy and safety of propionyl-L-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment.

2011

Alimentary pharmacology & therapeutics

Mikhailova TL, Sishkova E, Poniewierka E, Zhidkov KP, Bakulin IG +15 more

Plain English
In this study, researchers looked at the effects of propionyl-L-carnitine (PLC) on patients with mild-to-moderate ulcerative colitis (UC) who were already stable on treatment. They found that 72% of patients taking PLC had a positive response to treatment, compared to 50% in the placebo group, showing that PLC may help improve symptoms. The treatment was generally safe, with side effects mostly related to the stomach. Who this helps: This helps patients with ulcerative colitis looking for better management options.

PubMed

[Video capsule endoscopy in the diagnostics of small intestine diseases].

2008

Vestnik khirurgii imeni I. I. Grekova

Nakatis IaA, Borisov AE, Kashchenko VA, Sishkova EA, Raspereza DV +3 more

Plain English
This study looked at a new method called video capsule endoscopy, which lets doctors see the inside of the small intestine without surgery. The researchers found that this method is useful for diagnosing various small intestine issues, including gastrointestinal bleeding and diseases like Crohn's and celiac disease. It’s important because it offers a safe and easy way to identify problems in the small intestine, helping doctors make better treatment decisions. Who this helps: This helps patients with small intestine diseases by providing more accurate diagnoses.

PubMed

[A functional-morphological study of the mucociliary system at stages in the disease in patients with chronic bronchitis].

1997

Terapevticheskii arkhiv

Kobylianskiĭ VI, Kokosov AN, Cherniakova DN, Punin AA, Sishkova EA

Plain English
This study looked at how the mucociliary system (the body’s way of clearing mucus from the lungs) changes in patients with chronic bronchitis at different stages of the disease. Researchers found specific changes in mucociliary function based on the severity of the illness, the type of bronchitis, and the level of the bronchial system affected. Understanding these changes is important because it may lead to better treatments for chronic bronchitis. Who this helps: This helps patients with chronic bronchitis and their doctors.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.